Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

How to treat actinic keratosis? An update
Cláudia Costa, Massimiliano Scalvenzi, Fabio Ayala, et al.
Journal of Dermatological Case Reports (2015) Vol. 9, Iss. 2
Open Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

Current perspective on actinic keratosis: a review
Julia A. Siegel, Kaveri Korgavkar, Martin A. Weinstock
British Journal of Dermatology (2016) Vol. 177, Iss. 2, pp. 350-358
Closed Access | Times Cited: 171
Nanoparticles for topical drug delivery: Potential for skin cancer treatment
Vinu Krishnan, Samir Mitragotri
Advanced Drug Delivery Reviews (2020) Vol. 153, pp. 87-108
Closed Access | Times Cited: 159
Current therapies for actinic keratosis
Caterina Dianzani, Claudio Conforti, Roberta Giuffrida, et al.
International Journal of Dermatology (2020) Vol. 59, Iss. 6, pp. 677-684
Open Access | Times Cited: 84
Actinic keratosis – review for clinical practice
Erika C. V. de Oliveira, Valéria R. V. da Motta, Paola C. Pantoja, et al.
International Journal of Dermatology (2018) Vol. 58, Iss. 4, pp. 400-407
Closed Access | Times Cited: 82
Topically Applied Therapies for the Treatment of Skin Disease: Past, Present, and Future
Marc B. Brown, Adrian Williams, Robert P. Chilcott, et al.
Pharmacological Reviews (2024) Vol. 76, Iss. 5, pp. 689-790
Open Access | Times Cited: 7
Topical 5-Fluorouracil is a Novel Targeted Therapy for the Keratocystic Odontogenic Tumor
Nicholas J. Ledderhof, Marco Caminiti, Grace Bradley, et al.
Journal of Oral and Maxillofacial Surgery (2016) Vol. 75, Iss. 3, pp. 514-524
Closed Access | Times Cited: 59
Mediators of Inflammation in Topical Therapy of Skin Cancers
Vlad Mihai Voiculescu, Cristina Lisievici, Mihai Lupu, et al.
Mediators of Inflammation (2019) Vol. 2019, pp. 1-15
Open Access | Times Cited: 48
Novel approaches for managing aged skin and nonmelanoma skin cancer
Kristina Todorova, Anna Mandinova
Advanced Drug Delivery Reviews (2020) Vol. 153, pp. 18-27
Closed Access | Times Cited: 45
A review of BF-200 ALA for the photodynamic treatment of mild-to-moderate actinic keratosis
Uwe Reinhold
Future Oncology (2017) Vol. 13, Iss. 27, pp. 2413-2428
Open Access | Times Cited: 42
Prevalence and risk factors of actinic keratosis in patients attending Italian dermatology clinics
Maria Concetta Fargnoli, G. F. Altomare, Elisa Benati, et al.
European Journal of Dermatology (2017) Vol. 27, Iss. 6, pp. 599-608
Closed Access | Times Cited: 41
Structured Expert Consensus on Actinic Keratosis: Treatment Algorithm Focusing on Daylight PDT
Piergiacomo Calzavara‐Pinton, Merete Hædersdal, Kirk Barber, et al.
Journal of Cutaneous Medicine and Surgery (2017) Vol. 21, Iss. 1_suppl, pp. 3S-16S
Open Access | Times Cited: 37
5-Fluorouracil Is Associated With a Decreased Recurrence Risk in Odontogenic Keratocyst Management: A Retrospective Cohort Study
Marco Caminiti, Mohamed El-Rabbany, Justin Y Jeon, et al.
Journal of Oral and Maxillofacial Surgery (2020) Vol. 79, Iss. 4, pp. 814-821
Closed Access | Times Cited: 32
Comparison of the Treatment Guidelines for Actinic Keratosis: A Critical Appraisal and Review
Patrick Fleming, Stephanie Zhou, Robert Bobotsis, et al.
Journal of Cutaneous Medicine and Surgery (2017) Vol. 21, Iss. 5, pp. 408-417
Closed Access | Times Cited: 28
<p>Clinical utility of daylight photodynamic therapy in the treatment of actinic keratosis – a review of the literature</p>
Mimi Nguyen, Simran Sandhu, Raja K. Sivamani
Clinical Cosmetic and Investigational Dermatology (2019) Vol. Volume 12, pp. 427-435
Open Access | Times Cited: 23
If patients had a choice – Treatment satisfaction and patients’ preference in therapy of actinic keratoses
Berenice M. Lang, Sebastian Zielbauer, Henner Stege, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2024) Vol. 22, Iss. 10, pp. 1362-1368
Open Access | Times Cited: 2
In vivo Confocal Laser Microscopy for monitoring of actinic keratosis treatment: a comparison with histopathologic assessment after treatment with topical 5% 5‐fluorouracil
Priscila Ishioka, Marcus Maia, Sarita Bartholomei Rodrigues, et al.
Journal of the European Academy of Dermatology and Venereology (2017) Vol. 32, Iss. 7, pp. 1155-1163
Closed Access | Times Cited: 17
Daylight versus conventional photodynamic therapy for the treatment of actinic keratosis: A meta-analysis of randomized controlled trials
Xueling Mei, Li Wang, Ruina Zhang, et al.
Photodiagnosis and Photodynamic Therapy (2018) Vol. 25, pp. 23-28
Closed Access | Times Cited: 17
Efficacy of ingenol mebutate gel for actinic keratosis in patients treated by thiazide diuretics
Elena Campione, Monia Di Prete, Laura Diluvio, et al.
Clinical Cosmetic and Investigational Dermatology (2016) Vol. Volume 9, pp. 405-409
Open Access | Times Cited: 16
Are actinic keratoses really squamous cell cancer? How do we know if they would become malignant?
Claudio Conforti, Emanuela Beninati, Caterina Dianzani
Clinics in Dermatology (2017) Vol. 36, Iss. 3, pp. 430-432
Closed Access | Times Cited: 15
Ingol and Ingenol-Type Diterpenes from Euphorbia trigona Miller with Keratinocyte Inhibitory Activity
Reham Hammadi, Norbert Kúsz, Csilla Zsuzsanna Dávid, et al.
Plants (2021) Vol. 10, Iss. 6, pp. 1206-1206
Open Access | Times Cited: 11
Aktinische Keratosen
Theresa Hommel, Rolf‐Markus Szeimies
Der Hautarzt (2016) Vol. 67, Iss. 11, pp. 867-875
Closed Access | Times Cited: 10
International time trends and differences in topical actinic keratosis therapy utilization
Heather J. Zhao, Inna Ushcatz, Mina Tadrous, et al.
JAAD International (2024) Vol. 16, pp. 18-25
Open Access | Times Cited: 1
Wenn der Patient die Wahl hat – Therapiezufriedenheit und Patientenpräferenzen bei der Behandlung aktinischer Keratosen
Berenice M. Lang, Sebastian Zielbauer, Henner Stege, et al.
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2024) Vol. 22, Iss. 10, pp. 1362-1370
Open Access | Times Cited: 1
Erythema multiforme as a reaction to imiquimod 5&#37; cream
Daniel A. Yanes, Jessica Kaffenberger, David R. Carr
Dermatology Online Journal (2017) Vol. 23, Iss. 2
Open Access | Times Cited: 10
Ingenol mebutate in the treatment of actinic keratoses: clearance rate and adverse effects
Maria Isabel Ramos Saraiva, Larissa Karine Leite Portocarrero, Marcella Amaral Horta Barbosa Vieira, et al.
Anais Brasileiros de Dermatologia (2018) Vol. 93, Iss. 4, pp. 529-534
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top